Abhishek Srivastava
Geen lopende functies
Vermogen: 93 $ op 30-04-2024
Loopbaan van Abhishek Srivastava
Eerdere bekende functies van Abhishek Srivastava
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 04-08-2022 | 01-10-2023 |
| ATHENEXPAR | Corporate Officer/Principal | - | - |
Opleiding van Abhishek Srivastava
| University of Louisville School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
- Beurs
- Insiders
- Abhishek Srivastava
- Ervaring
